* Surgical indication is similar according to age, we obtained 163 patients < 75 years , 36 patients 75-80 years and 15 >80 years.
AGE 2012-2014 2014-2016 2016-2018 Total.
<75 64(75,2%) 65(78,3%) 34(69,3%) 163
75-79 17(20%) 12(14,4%) 10(20,4%) 39
>80 4(4,7%) 6(7,2%) 5(10,2%) 15
Total 85(100%) 83(100%) 49(100%) 217
No significant differences ( p<0.05) were found in the demographic variables. BMI(median range): 25,6 (16.6-17.3) Gestations(median range): 3(0-8), Hypertension: 53,9% (117/217), Diabetes: 21,2% (23/217), Dyslipemia: 36,9% (80/217), Cardiovasular disease: 10,1% (22/217) , Respiratory disease: 10,6% (23/217), Prior Surgery Prolapse: 18,4% (40/217), Anticoagulant: 4,6% (10/217) , Antiaggregate: 18% (39/217). Results are sumarized in table 1.
TOTAL <75 75-80 >80
Time(min) 160(90-360) 180( 90-360) 150(90-300) 120( 90-300)
Days Hospit 3(2-13) 3 ( 2-13) 3(2-9) 3( 2-4)
Conversion 0%
* No differences found ( p<0,05) between age groups. There was no conversion to open surgery .
*No significant differences ( p<0.05) were found in the complications between age groups. Intraoperative complications (1.8% (3/21)) were bladder perforation, vaginal perforation and bowel perforation. In Postoperative comlications we has : Clavien-Dindo I 2,3%(5/217): 2 vaginal bleeding and 3 constipation; Clavien-Dindo II 9,2%(20/217): 12 urinary tract infections, 5 haematomas ; 2 wound Infection, 1 deep-vein thrombosis; Clavien-Dindo III 1,8%(4/217): 1 anaphylactic shock, 1 ureteral fistula, 1 bowel obstruction , 1 eventration. There were no Clavien-Dindo IV-V. Results are sumarized in table 2.